Skip to main menu Skip to main content Skip to footer

Research

Advancing Eye Health

Research

Driving innovation and improving outcomes through ophthalmic research, clinical trials, data, and device innovation.

Our Research Projects

Explore the clinical trials, studies and innovations helping advance the future of eye care.

Efficacy and Safety of Next-Generation IOL in Cataract Surgery

A multicentre, randomised, double-masked study evaluating visual outcomes and patient satisfaction.

PHASE 3 STUDY
OBJECTIVE

To evaluate the visual performance and safety of the next-generation intraocular lens over 12 months.

APPROACH

Randomised, double-masked trial across 12 sites. Patients assessed pre-operatively and at 1, 3, 6, and 12 months post-surgery.

INSIGHT

Significantly improved visual outcomes with a favourable safety profile through 12 months.

CLINICAL RELEVANCE

Supports the use of this IOL to deliver consistently high-quality vision and patient satisfaction in routine cataract surgery.

Glaucoma Trial

IoES is home to the first phase 3 glaucoma trial ever performed in Ireland.  IoES is among the first clinics in Europe to utilise a dropless glaucoma technology (treating glaucoma without using lifelong daily eye drops) that is fully licensed in the United States but currently available only on trial in Europe.

PHASE 3 STUDY

Cataract Surgery Clinical Trial

IoES has run several trials utilising the newest intraocular lens implant technology used in all cataract surgeries.  Our surgeons advise companies manufacturing intra-ocular lenses on the design of their lenses.

PHASE 3 STUDY

Industry Leading Treatments for Ocular Surface Disoders

IoES ran the first dedicated ocular surface clinic treating dry eyes, meibomian gland dysfunction and blepharitis and has been nominated by Lumenis as their Irish reference site for their intense pulse light laser platform.

PHASE 3 STUDY

Clinical Research

IOES clinical research has a proven track record of attracting multimillion-euro grants, with successful spinout activity and exit to one of the world’s top five pharmaceutical companies.

As an Irish clinical research function focused on ocular health science and ophthalmology innovation, IOES clinical research supports the development of novel products, services and technologies that address unmet clinical needs in eye care.

IOES clinical research works with pharmaceutical, optical imaging and academic partners globally to help accelerate innovation and support advances in ophthalmic care.

⇧